0.2787USD-0.21%Mkt Cap: 12.79M USDP/E: —Last update: 2026-06-01
Theriva Biologics, Inc., a clinical-stage company, develops therapeutics to treat cancer and related diseases in areas of high unmet need in the United States. Its lead product candidate, VCN-01 (zabilugene almadenorepve…
Industry Peers
Biotechnology111.39BUSDP/E 26.0
100.62BDKKP/E 19.4
62.97BUSDP/E 14.7
48.39BEURP/E 31.7
44.65BEURP/E 37.2
40.10BUSDP/E 75.3
35.22BUSD—
32.91BSEKP/E 48.6
Indicators:|
Key Statistics
Company
Market Cap12.79M USD
Enterprise Value3.44M USD
Revenue (TTM)300.00K USD
Gross Profit300.00K USD
Net Income (TTM)-23.74M USD
Revenue/Share0.0140 USD
Last Price0.2787 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees15
CountryUS
SectorHealthcare
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)-1.42
PEG—
EV/EBITDA-0.27
EV/Revenue11.48
P/S43.41
P/B0.66
EPS (TTM)-0.58
EPS (Forward)-0.20
52W Range
0.160017% of range0.8600
52W High0.8600 USD
52W Low0.1600 USD
Profitability
Gross Margin100.00%
Oper. Margin-709.00%
EBITDA Margin0.00%
Profit Margin0.00%
ROE-154.32%
ROA-62.08%
Growth
Revenue Growth—
Earnings Growth—
Cash Flow & Leverage
Operating CF-16.67M USD
CapEx (TTM)35.00K USD
FCF Margin-1623.42%
FCF Yield-38.08%
Net Debt-10.74M USD
Net Debt/EBITDA0.85
Balance Sheet
Debt/Equity0.17
Current Ratio1.63
Quick Ratio1.58
Book Value/Sh0.4310 USD
Cash/Share0.3140 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay DateAug 13, 2018
Splits
Last Split1:25
Split DateAug 26, 2024
Analyst Consensus
Rating—
Target (Mean)2.500 USD
Target Range1.000 USD – 4.000 USD
# Analysts2
Ownership
Shares Out.45.89M
Float45.14M
Insiders1.70%
Institutions4.32%
Short Interest
Short Ratio0.1d
Short % Float8.85%
Short % Out.8.85%
Shares Short4.06M
Short (prev mo.)2.54M
Technical
SMA 500.2904 (-4.0%)
SMA 2000.2903 (-4.0%)
Beta1.18
S&P 52W Chg27.94%
Avg Vol (30d)27.07M
Avg Vol (10d)1.77M
Technical Indicators
RSI (14)43.9
MACD-0.0051
MACD Signal0.0015
MACD Hist.-0.0066
BB Upper0.3992 USD
BB Middle0.3246 USD
BB Lower0.2501 USD
BB Width45.93%
ATR (14)0.0316 USD
Vol Ratio (20d)0.66x